Tianjin TEDA Biomedical Engineering (TJJ) Stock Overview

Engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. More details

TJJ fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€35M)

TJJ Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

479,582 investors already sharing narratives

View all narratives

Tianjin TEDA Biomedical Engineering Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tianjin TEDA Biomedical Engineering
Historical stock prices
Current Share Price	HK$0.012
52 Week High	HK$0.047
52 Week Low	HK$0.01
Beta	-0.46
1 Month Change	-4.00%
3 Month Change	-48.94%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-62.38%

Recent updates

Shareholder Returns

	TJJ	DE Chemicals	DE Market
7D	-4.0%	0.9%	0.1%
1Y	n/a	2.4%	-0.5%

Return vs Industry: Insufficient data to determine how TJJ performed against the German Chemicals industry.

Return vs Market: Insufficient data to determine how TJJ performed against the German Market.

Price Volatility

Is TJJ's price volatile compared to industry and market?
TJJ volatility
TJJ Average Weekly Movement	14.8%
Chemicals Industry Average Movement	5.2%
Market Average Movement	5.3%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: TJJ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: TJJ's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2000	273	Li Sun	bioteda.com

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company’s biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas.

Tianjin TEDA Biomedical Engineering Company Limited Fundamentals Summary

How do Tianjin TEDA Biomedical Engineering's earnings and revenue compare to its market cap?
TJJ fundamental statistics
Market cap	€34.58m
Earnings (TTM)	-€11.75m
Revenue (TTM)	€67.67m

0.5x

P/S Ratio

-2.9x

P/E Ratio

Is TJJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TJJ income statement (TTM)
Revenue	CN¥522.97m
Cost of Revenue	CN¥552.36m
Gross Profit	-CN¥29.40m
Other Expenses	CN¥61.42m
Earnings	-CN¥90.82m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.043
Gross Margin	-5.62%
Net Profit Margin	-17.37%
Debt/Equity Ratio	3,591.4%

How did TJJ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/22 20:26
End of Day Share Price	2026/07/22 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tianjin TEDA Biomedical Engineering Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Tianjin TEDA Biomedical Engineering Company LimitedDB:TJJ Stock Report